COMPANY PROFILE

BioXell

Explore full profile

BioXell is a biomedical research institute focusing on chronic inflammatory disease and autoimmunity

Milan, ItalyFounded 2002Biotech & Life Sciences

Valuation $25–50M Last recorded · 2009

Headcount <100 Current team size

Total funding $50–100M Disclosed equity funding

Unlock exact values

At a glance

Status: Acquired
Founded: 2002
Headquarters: Milan, Italy
Employees: 14
Open positions: None listed
Dealroom signal: 58.7/100
Industry: Health, Event Tech
Sub-industry: BioTechnology
Sector: Biotech & Life Sciences, Biotechnology, Hard Tech, DT and LS, science-based
Client focus: b2c
Links: Website LinkedIn X

Knowledge graph

Founder mafia, market maps, research and news connected to this company by Dealroom

Funding history

8 recorded events

Company financing events and reported valuations.

Deal type	Date	Amount	Valuation	Investors	Source
ACQUISITIONOther financing	Nov 2009	$41M	$41M	Cosmo Pharmaceuticals	—
LATE VCOther financing	Mar 2007	$0	—	Thuja Capital	—

Showing the latest 2 of 8 recorded eventsBook a demo for the full funding history →

Growth signals

BioXell website traffic

Latest recorded traffic for BioXell is 260 monthly website visits, up 188.9% over the last three months. BioXell's team declined 6.7% over the past year.

Latest monthly visits260 3-month web change+188.9% 1-year team growth-6.7%

Monthly website visitsApr 2016–Jul 2026

Explore monthly traffic historyTrack growth over time and compare with peersBook a demo

Summary metrics are public; monthly history is available with a demoCompare with peers →

Similar companies

Closest operating peers by Dealroom taxonomy

Company identity and context are open; selected comparison metrics preview what is available on the platform.

Company	Headquarters	Status	Employees	Total funding	Valuation
HLHATCHMORE LabsGet the best from your medication therapy	Grünwald, Germany	Operational	2	—	—
RARareCanAn organisation for the purpose of speeding up research and ultimately improving outcomes for people with rarer forms of cancer	Hexham, United Kingdom	Operational
INIntellegensHelping clients accelerate innovation by using our unique deep learning solutions to extract valuable information from existing processes and data	Cambridge, United Kingdom	Operational
AIAioCareManufactures a personal device for real-time monitoring and treating lung-related diseases	Warsaw, Poland	Operational
SHSyrona HealthDigital therapeutics for Endometriosis and Gynaecological Health	London, United Kingdom	Operational
GEGenomelinkPersonal DNA cloud for trait and ancestry analysis	Berkeley, United States	Operational
BIBiomax InformaticsComputational solutions for better decision making and knowledge management in the life science industry	Planegg, Germany	Acquired
INInovivQuantitative proteomics panels for drug development acceleration	London, United Kingdom	Operational